Milestone Pharmaceuticals Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
(technical difficulty) one of the analysts here on Oppenheimer's biotech equity research team. Welcome back to another session here at our 33rd Annual Healthcare Conference. I'm very delighted to have with us Milestone Pharmaceuticals as our next presenting company, from which we have three members of the team: Amit Hasija, who is CFO and EVP of Corporate Development; Lorenz Muller, who is Chief Commercial Officer; and David Bharucha, who is Chief Medical Officer.
We will have some time for questions at the end. (Conference Instructions)
And with that, I'll hand it over to Amit.
Thank you for that introduction, Leland, and thank you to all the Oppenheimer colleagues for inviting us to this conference again this year. Very excited to take you through the Milestone story as well as some recent events.
First, I'll flash up here the forward-looking statements, encourage you to take a look at this and read it
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
